Eukaryotic Transcription Inhibitors

Eukaryotic transcription inhibitors contain a DNA binding domain that recognizes specific regulatory sequences and a repressor domain that blocks transcription. The repressor domain can bind to other proteins, including activators, co-activators, and co-repressors. These domains are often interchangeable, allowing different repressor domains to associate with the same DNA binding domain.

Transcription inhibitors can block activator binding through competitive inhibition or allosteric interference. In competitive inhibition, the inhibitor directly binds to the cis-regulatory sequence, preventing the activator from accessing it. Alternatively, the inhibitor binds adjacent to the activator site and uses its repressor domain to interact with the activator, physically preventing its binding to the regulatory sequence.

Co-repressors are proteins recruited by transcription inhibitor repressor domains to actively inhibit transcription. Many co-repressors function as histone deacetylases, histone methyltransferases, and chromatin remodelers. These enzymatic activities tightly pack DNA in nucleosomes, restricting access of transcription factors and polymerase to regulatory sites and effectively silencing gene expression.

Transcription inhibitors can competitively bind to the binding sites of general transcription factors on DNA, preventing assembly of the transcriptional machinery. By occupying sites where these factors normally bind, inhibitors physically block the formation of the pre-initiation complex required for transcription initiation at the promoter.

Gene silencing occurs when a transcription inhibitor simultaneously binds to a protein within the transcriptional machinery and to a DNA sequence near the transcription start site, anchoring the machinery in place. This locks or disorganizes the transcription initiation complex, preventing it from functioning. For example, the yeast inhibitor α-2 binds as a dimer to both the activator GRM and adjacent DNA sequences.

Some transcription inhibitors bind to their own inhibitory cis-regulatory sequences, blocking transcription initiation even when activators are present on the regulatory region. This mechanism allows inhibitors to establish repression independently of activator activity, providing an additional layer of gene expression control.

Repressor domains are categorized by their amino acid composition, including alanine-rich, glutamine-rich, and proline-rich domains. They can also be classified as acidic or basic domains, and as hydrophilic or hydrophobic. These diverse domain types are often interchangeable, allowing flexibility in how inhibitors regulate transcription across different genes.